ALEXUS GOODSON: Open Payments
NPI 1285261404 · INDIANOLA, IA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$566 in 43 payments from 7 companies in 2025. Trend: 2023 $949 · 2024 $724 · 2025 $566
Food & beverage: $547Education: $19
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 18 | $204 |
| Lilly USA, LLC | 13 | $148 |
| ABBVIE INC. | 5 | $93 |
| Novo Nordisk Inc | 2 | $43 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $33 |
| GlaxoSmithKline, LLC. | 2 | $29 |
| Cranial Technologies, Inc | 1 | $15 |
Products named: MOUNJARO, NURTEC ODT, ELIQUIS, JARDIANCE, UBRELVY, Ozempic, QULIPTA, SHINGRIX.
Industry payments across IA — which companies pay providers there.
